Apnimed, Inc. (APMD)

NASDAQ: APMD · Real-Time Price · USD

28.08

-0.71 (-2.47%)

Sep 9, 2026, 4:00 PM EDT - Market closed

Apnimed Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	120.15	38.47	8.01	-	1
Revenue Growth	11915.00%	380.12%	-	-	-
Gross Profit	112.61	31.77	4.64	-	1
Operating Income	41.34	-53.82	-114.23	-48.52	-26.55
Net Income	-31.83	-128.19	-111.31	-80.25	-26.21
Earnings Per Share	-6.28	-23.76	-20.73	-27.84	-11.04
EPS Growth	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	46.89	41.89	68.35	173.96	133.83
Total Debt	39.35	41.52	1.1	-	0.11
Net Cash (Debt)	7.54	0.37	67.26	173.96	133.72
Net Cash Growth	-94.36%	-99.45%	-61.34%	30.09%	-
Net Cash Per Share	1.39	0.07	12.52	60.35	56.31

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	-69.19	-77.83	-110.21	25.41	-26.13
Capital Expenditures	-	-	-0.07	-0.05	-
Free Cash Flow	-69.19	-77.83	-110.28	25.37	-26.13
Free Cash Flow Growth	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	93.73%	82.60%	57.95%	-	100.00%
Operating Margin	34.41%	-139.91%	-1425.79%	-	-2654.80%
Pretax Margin	32.46%	-150.91%	-1354.84%	-	-2620.80%
Profit Margin	-26.49%	-333.25%	-1389.23%	-	-2620.80%
FCF Margin	-57.59%	-202.33%	-1376.42%	-	-2612.90%